Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange

Custom Health Secures TSX Listing and $60M in Financing to Scale Remote Care Platform

By The Northwire Desk — AI Analysis Jun 22, 2026 · 17:46 CHLT NaN
Executive Summary
  • Custom Health Holdings Inc. received final TSX approval for its common shares to commence trading on June 24, 2026.
  • The listing follows the completion of a plan of arrangement to acquire 100% of Custom Delaware.
  • The company is no longer classified as a "venture issuer" under NI 51-102.
  • Multiple financing arrangements were executed totaling up to US$50 million in convertible/promissory notes and C$10 million in credit facilities, accompanied by warrant issuances.
  • Specific facilities include Funicular senior secured convertible notes (up to US$20M), Yorkville promissory notes (up to US$15M), 102 Saskatchewan unsecured credit facility (up to US$15M), and FairCap secured credit facility (C$10M).
  • Warrants carry exercise prices tied to VWAP or a US$8.00 floor, with coverage ratios ranging from 50% to 100% of principal.
Material Impact
  • The announcement represents a standard corporate evolution milestone rather than an unexpected operational or financial breakthrough.
  • The TSX listing and venture issuer status change improve capital market access, liquidity, and public profile, which are structurally positive for a growth-stage healthcare technology company.
  • The $60 million in debt/equity-linked financing provides immediate liquidity to fund acquisitions, working capital, and integration of Custom Delaware.
  • However, the financing structure introduces significant potential dilution through warrants and convertible notes, alongside fixed interest obligations (e.g., 12% annual interest on the Saskatchewan facility).
  • No immediate revenue, margin, or cash flow impact is disclosed; the capital is earmarked for strategic deployment rather than current operations.
CHLT · Price
Company Overview
  • Custom Health Holdings Inc. operates in the healthcare technology sector, focusing on technology-enabled medication management, pharmacy services, and remote clinical care.
  • The recent plan of arrangement consolidates 100% ownership of Custom Delaware, suggesting a vertical or horizontal integration within the remote care and pharmacy management space.
  • Transitioning to a TSX-listed, non-venture issuer status positions the company to access broader institutional capital and pursue larger-scale acquisitions or partnerships.
Read the original news release →